Fact CheckerSign in

NCT06706999Completed

Feasibility and Acceptability of PREVAIL (PREserving Valued Activities In Life)

Pilot Study of Feasibility and Acceptability of PREVAIL (PREserving Valued Activities In Life)

Source: ClinicalTrials.gov · Last updated 27 Jul 2026

Brief summary (registry, in English)

The goal of this clinical trial is to learn if the PREVAIL model of care is a feasible way to integrate rehabilitation into routine rheumatology care for adults with rheumatoid arthritis (RA). The model of care consists of three essential components: a screening tool (Daily Activity and Participation Screen (DAPS)), a recommendation to the rheumatology clinician regarding rehabilitation referral and exercise, and an online exercise resource tailored for adults with RA. Participants will complete baseline assessments before their scheduled routine visit with a rheumatology clinician, attend their visit, receive their exercise and/or rehabilitation recommendation, and complete follow-up assessments roughly three months after their visit. Based on a participant's DAPS score, they may be recommended to complete a brief consultation call with a study physical therapist, who may or may not refer them to physical therapy (PT). Participants may also be asked to elaborate on their experience with the PREVAIL model of care in an interview.

Status (registry)
Completed
Study type
Interventional
Enrollment
63 (actual)
First submitted
22 Nov 2024
Start date
31 Mar 2025
Primary completion date
17 Oct 2025
Lead sponsor
University of North Carolina, Chapel Hill
NCT number
NCT06706999

What you commit to

  • Study type: Interventional
  • Participants enrolled: 63
  • From 31 Mar 2025 to the primary completion date, 17 Oct 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Recent (within the last 6 months) major surgery requiring overnight hospital admission and/or resulting in functional loss, requiring rehabilitation
  • Upcoming (within the next 6 months) major surgery requiring overnight hospital admission and/or resulting in functional loss, requiring rehabilitation

Other illness

  • Significant cognitive impairment
  • Condition that restricts ability to complete surveys and patient reported outcomes
  • Severe hearing or visual impairment
  • Serious/terminal illness as indicated by referral to hospice or palliative care

Age

  • Under the age of 18

Other

  • No documented diagnosis of RA
  • Unable to speak or read English
  • Current participation in any other study related to RA
  • Current or recent (within the last six months) participation in PT

Who the study is looking for

  • Over the age of 18
  • Clinician diagnosis of RA as defined by International Classification of Diseases 10 (ICD-10) code
  • Receiving routine care from a UNC rheumatology clinician
  • Have an upcoming scheduled visit with a UNC rheumatology clinician for a routine follow up

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of North Carolina at Chapel Hill
Coordinator of this site? Confirm its status
Chapel HillUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.